Cargando…

384. Findings From a Candida auris Admission Screening Pilot in New York State

BACKGROUND: Candida auris is an emerging multidrug-resistant yeast which can spread within healthcare facilities and is associated with significant morbidity. Over 160 clinical cases have been reported in NYS. This pilot aims to assess the feasibility of C. auris admission screening and to better un...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufort, Elizabeth M, Erazo, Richard, Quinn, Monica, Chaturvedi, Sudha, Vallabhaneni, Snigdha, Haley, Valerie B, Lutterloh, Emily, Kuang, Jiankun, Stover, Carolyn, Bucher, Coralie, McDonald, Robert, Adams, Eleanor H, Blog, Debra S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253578/
http://dx.doi.org/10.1093/ofid/ofy210.395
_version_ 1783373528120164352
author Dufort, Elizabeth M
Erazo, Richard
Quinn, Monica
Chaturvedi, Sudha
Vallabhaneni, Snigdha
Haley, Valerie B
Lutterloh, Emily
Kuang, Jiankun
Stover, Carolyn
Bucher, Coralie
McDonald, Robert
Adams, Eleanor H
Blog, Debra S
author_facet Dufort, Elizabeth M
Erazo, Richard
Quinn, Monica
Chaturvedi, Sudha
Vallabhaneni, Snigdha
Haley, Valerie B
Lutterloh, Emily
Kuang, Jiankun
Stover, Carolyn
Bucher, Coralie
McDonald, Robert
Adams, Eleanor H
Blog, Debra S
author_sort Dufort, Elizabeth M
collection PubMed
description BACKGROUND: Candida auris is an emerging multidrug-resistant yeast which can spread within healthcare facilities and is associated with significant morbidity. Over 160 clinical cases have been reported in NYS. This pilot aims to assess the feasibility of C. auris admission screening and to better understand its role in controlling spread of C. auris in an area where it has emerged. METHODS: One hospital and two nursing homes (NHs) with known prior cases participated (one NH and hospital are closely associated and are reported together). Patients were screened on admission to any of three hospital intensive care units (medical, cardiac, pulmonary) or to a ventilator unit in the NHs from November 2017 to April 2018. Screening consisted of bilateral nares and axilla/groin swabs sent to the NYS Department of Health Wadsworth Center (WC) for a WC-developed C. auris real-time polymerase chain reaction (rt-PCR) test. Specimens with detection of C. auris on rt-PCR underwent fungal culture. Facilities were alerted of positive results and infection control precautions were promptly initiated. RESULTS: To date, 575 patients (1,371 samples) were screened. Of patients not previously known to be colonized, 39 had C. auris detected on rt-PCR; 34 confirmed by C. auris culture at either site and one culture pending. Of these, 30 (88%) were detected and confirmed from the axilla/groin specimen (Figure 1). Mean age was 76 years and 59% were females. Patients had significant healthcare facility exposure (Figure 2). Eleven (32%) were from NH-A and 23 (68%) from the hospital/NH-B combined. Rates of positivity were 16.2% (11/68) for NH-A and 4.6% (23/498) for the hospital/NH-B. CONCLUSION: C. auris rt-PCR is a useful tool within an admission screening program; however, more accessible and affordable rapid laboratory diagnostics are urgently needed. The axilla/groin site detected the majority of colonized individuals. Admission screening was feasible and increased facility knowledge of colonization status, which led to earlier implementation of infection control precautions potentially limiting spread. However, further study is needed to assess transmission dynamics and potential impact of admission screening on control of C. auris within an outbreak or endemic setting. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253578
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62535782018-11-28 384. Findings From a Candida auris Admission Screening Pilot in New York State Dufort, Elizabeth M Erazo, Richard Quinn, Monica Chaturvedi, Sudha Vallabhaneni, Snigdha Haley, Valerie B Lutterloh, Emily Kuang, Jiankun Stover, Carolyn Bucher, Coralie McDonald, Robert Adams, Eleanor H Blog, Debra S Open Forum Infect Dis Abstracts BACKGROUND: Candida auris is an emerging multidrug-resistant yeast which can spread within healthcare facilities and is associated with significant morbidity. Over 160 clinical cases have been reported in NYS. This pilot aims to assess the feasibility of C. auris admission screening and to better understand its role in controlling spread of C. auris in an area where it has emerged. METHODS: One hospital and two nursing homes (NHs) with known prior cases participated (one NH and hospital are closely associated and are reported together). Patients were screened on admission to any of three hospital intensive care units (medical, cardiac, pulmonary) or to a ventilator unit in the NHs from November 2017 to April 2018. Screening consisted of bilateral nares and axilla/groin swabs sent to the NYS Department of Health Wadsworth Center (WC) for a WC-developed C. auris real-time polymerase chain reaction (rt-PCR) test. Specimens with detection of C. auris on rt-PCR underwent fungal culture. Facilities were alerted of positive results and infection control precautions were promptly initiated. RESULTS: To date, 575 patients (1,371 samples) were screened. Of patients not previously known to be colonized, 39 had C. auris detected on rt-PCR; 34 confirmed by C. auris culture at either site and one culture pending. Of these, 30 (88%) were detected and confirmed from the axilla/groin specimen (Figure 1). Mean age was 76 years and 59% were females. Patients had significant healthcare facility exposure (Figure 2). Eleven (32%) were from NH-A and 23 (68%) from the hospital/NH-B combined. Rates of positivity were 16.2% (11/68) for NH-A and 4.6% (23/498) for the hospital/NH-B. CONCLUSION: C. auris rt-PCR is a useful tool within an admission screening program; however, more accessible and affordable rapid laboratory diagnostics are urgently needed. The axilla/groin site detected the majority of colonized individuals. Admission screening was feasible and increased facility knowledge of colonization status, which led to earlier implementation of infection control precautions potentially limiting spread. However, further study is needed to assess transmission dynamics and potential impact of admission screening on control of C. auris within an outbreak or endemic setting. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253578/ http://dx.doi.org/10.1093/ofid/ofy210.395 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Dufort, Elizabeth M
Erazo, Richard
Quinn, Monica
Chaturvedi, Sudha
Vallabhaneni, Snigdha
Haley, Valerie B
Lutterloh, Emily
Kuang, Jiankun
Stover, Carolyn
Bucher, Coralie
McDonald, Robert
Adams, Eleanor H
Blog, Debra S
384. Findings From a Candida auris Admission Screening Pilot in New York State
title 384. Findings From a Candida auris Admission Screening Pilot in New York State
title_full 384. Findings From a Candida auris Admission Screening Pilot in New York State
title_fullStr 384. Findings From a Candida auris Admission Screening Pilot in New York State
title_full_unstemmed 384. Findings From a Candida auris Admission Screening Pilot in New York State
title_short 384. Findings From a Candida auris Admission Screening Pilot in New York State
title_sort 384. findings from a candida auris admission screening pilot in new york state
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253578/
http://dx.doi.org/10.1093/ofid/ofy210.395
work_keys_str_mv AT dufortelizabethm 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT erazorichard 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT quinnmonica 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT chaturvedisudha 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT vallabhanenisnigdha 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT haleyvalerieb 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT lutterlohemily 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT kuangjiankun 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT stovercarolyn 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT buchercoralie 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT mcdonaldrobert 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT adamseleanorh 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate
AT blogdebras 384findingsfromacandidaaurisadmissionscreeningpilotinnewyorkstate